Showing results (341-350 of 452) with videos related to
Sort By:
Pageof 46
JAMA Neurology|May 3, 2021
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple SclerosisDamiano Baroncini, Marta Simone, Pietro Iaffaldano, et al.Journal of Neurology|August 20, 2020
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosisNancy D Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 22, 2020
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19Antonio Carotenuto, Laura De Giglio, Alessandro Chiodi, et al.Multiple Sclerosis and Related Disorders|June 30, 2026
Real-world analytical and clinical evaluation of the Siemens Atellica® immunoassay for plasma neurofilament light chain in multiple sclerosisValerio Nicolella, Carmela Polito, Vincenzo Criscuolo, et al.Health Information Science and Systems|October 22, 2025
Evaluating topological and graph-theoretical approaches to extract complex multimodal brain connectivity patterns in multiple sclerosisToni Lozano-Bagén, Eloy Martinez-Heras, Giuseppe Pontillo, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx studyBrian M Sandroff, Robert W Motl, Maria Pia Amato, et al.Journal of Neurology|August 27, 2024
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA)Clara Grazia Chisari, Maria Pia Amato, Alessia Di Sapio, et al.European Journal of Neurology|October 30, 2024
Association between CD20+ T lymphocytes and neuropsychological findings in multiple sclerosisAntonio Esposito, Fabrizia Falco, Giulia Scalia, et al.Multiple Sclerosis and Related Disorders|November 7, 2025
Anti-EBV antibody reduction during ocrelizumab treatment is not associated with multiple sclerosis outcomesAntonio Esposito, Luca Corsaro, Ilaria Delle Cave, et al.Toxins|November 10, 2022
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple SclerosisFederica Novarella, Antonio Carotenuto, Paolo Cipullo, et al.Pageof 46